Norris Lam

2.4k total citations
31 papers, 971 citations indexed

About

Norris Lam is a scholar working on Oncology, Molecular Biology and Ecology. According to data from OpenAlex, Norris Lam has authored 31 papers receiving a total of 971 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 10 papers in Molecular Biology and 7 papers in Ecology. Recurrent topics in Norris Lam's work include CAR-T cell therapy research (16 papers), Hydrology and Sediment Transport Processes (6 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). Norris Lam is often cited by papers focused on CAR-T cell therapy research (16 papers), Hydrology and Sediment Transport Processes (6 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). Norris Lam collaborates with scholars based in United States, Sweden and Italy. Norris Lam's co-authors include James N. Kochenderfer, Steven A. Rosenberg, John M. Rossi, Adrian Bot, Steven A. Feldman, Danielle Vanasse, Carol J. Thiele, Jennifer N. Brudno, James C. Yang and Richard M. Sherry and has published in prestigious journals such as Nature Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Norris Lam

30 papers receiving 959 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Norris Lam United States 13 727 431 234 221 197 31 971
Arletta Lozanski United States 8 451 0.6× 206 0.5× 109 0.5× 102 0.5× 226 1.1× 14 842
Tyler A. Longmire United States 8 330 0.5× 477 1.1× 87 0.4× 70 0.3× 205 1.0× 14 922
Julie Earl Spain 17 536 0.7× 391 0.9× 72 0.3× 108 0.5× 137 0.7× 50 1.0k
James Annis United States 9 246 0.3× 869 2.0× 125 0.5× 123 0.6× 43 0.2× 16 1.0k
Vitor H. Teixeira United Kingdom 10 154 0.2× 236 0.5× 38 0.2× 50 0.2× 126 0.6× 13 675
Joachim Wahl Germany 14 334 0.5× 186 0.4× 38 0.2× 40 0.2× 157 0.8× 28 531
Tapan Ganguly United States 12 132 0.2× 289 0.7× 45 0.2× 98 0.4× 57 0.3× 23 543
J. Jason Morton United States 14 316 0.4× 281 0.7× 77 0.3× 53 0.2× 144 0.7× 19 621
Weimin Wang China 10 560 0.8× 534 1.2× 31 0.1× 39 0.2× 555 2.8× 13 1.1k

Countries citing papers authored by Norris Lam

Since Specialization
Citations

This map shows the geographic impact of Norris Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norris Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norris Lam more than expected).

Fields of papers citing papers by Norris Lam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norris Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norris Lam. The network helps show where Norris Lam may publish in the future.

Co-authorship network of co-authors of Norris Lam

This figure shows the co-authorship network connecting the top 25 collaborators of Norris Lam. A scholar is included among the top collaborators of Norris Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norris Lam. Norris Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brown, Ian A., et al.. (2024). Seasonal optimisation of drone‐based photogrammetry in a heterogeneous boreal landscape. Applied Vegetation Science. 27(3). 1 indexed citations
2.
Weissler, Katherine A., et al.. (2024). Optimization of anti-CD19 CAR T cell production for treatment of patients with chronic lymphocytic leukemia. Molecular Therapy — Methods & Clinical Development. 32(1). 101212–101212. 2 indexed citations
3.
Lam, Norris, Richard Finney, Shicheng Yang, et al.. (2023). Development of a bicistronic anti-CD19/CD20 CAR construct including abrogation of unexpected nucleic acid sequence deletions. Molecular Therapy — Oncolytics. 30. 132–149. 9 indexed citations
4.
Brudno, Jennifer N., Nisha Patel, Lekha Mikkilineni, et al.. (2022). Transient Responses and Significant Toxicities Due to Cytopenias and Rashes with Anti-CD30 CAR T Cells for CD30-Expressing Lymphomas: Results of a Phase I Clinical Trial. Blood. 140(Supplement 1). 12731–12732. 2 indexed citations
5.
Lam, Norris, Stephanie Choi, Shicheng Yang, et al.. (2021). Development of a Bicistronic Anti-CD19/CD20 CAR Construct Including Optimization to Abrogate Retroviral Recombination Events. Blood. 138(Supplement 1). 4808–4808. 2 indexed citations
6.
Pegues, Melissa A., et al.. (2020). Design and Assessment of Novel Anti-CD30 Chimeric Antigen Receptors with Human Antigen-Recognition Domains. Human Gene Therapy. 32(13-14). 730–743. 9 indexed citations
7.
Pegues, Melissa A., Norris Lam, Danielle Vanasse, et al.. (2020). Development of CAR T Cells Expressing a Suicide Gene Plus a Chimeric Antigen Receptor Targeting Signaling Lymphocytic-Activation Molecule F7. Molecular Therapy. 29(2). 702–717. 82 indexed citations
8.
Lam, Norris, Nathan D. Trinklein, Benjamin Buelow, et al.. (2020). Anti-BCMA chimeric antigen receptors with fully human heavy-chain-only antigen recognition domains. Nature Communications. 11(1). 283–283. 94 indexed citations
9.
Liu, Zhihui, Xiyuan Zhang, Haiyan Lei, et al.. (2020). CASZ1 induces skeletal muscle and rhabdomyosarcoma differentiation through a feed-forward loop with MYOD and MYOG. Nature Communications. 11(1). 911–911. 36 indexed citations
10.
Brudno, Jennifer N., Norris Lam, Danielle Vanasse, et al.. (2020). Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma. Nature Medicine. 26(2). 270–280. 228 indexed citations
11.
Westerberg, Ida, et al.. (2019). Rapid Stage‐Discharge Rating Curve Assessment Using Hydraulic Modeling in an Uncertainty Framework. Water Resources Research. 55(11). 9765–9787. 18 indexed citations
13.
Westerberg, Ida, et al.. (2018). Estimating uncertainties in hydraulicallymodelled rating curves for discharge time series assessment. SHILAP Revista de lepidopterología. 40. 6013–6013. 3 indexed citations
14.
Westerberg, Ida, Norris Lam, & Steve W. Lyon. (2017). Can hydraulic-modelled rating curves reduce uncertainty in high flow data?. EGUGA. 10109. 1 indexed citations
15.
Veschi, Veronica, Zhihui Liu, Ty C. Voss, et al.. (2017). Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma. Cancer Cell. 31(1). 50–63. 72 indexed citations
16.
Veschi, Veronica, Zhihui Liu, Ty C. Voss, et al.. (2017). Abstract 3867: Epigenetic siRNA and chemical screens identify SETD8 inhibition as a therapeutic strategy to reactivate p53 in high-risk neuroblastoma. Cancer Research. 77(13_Supplement). 3867–3867.
17.
Kochenderfer, James N., Robert Somerville, Tangying Lu, et al.. (2017). Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy. Molecular Therapy. 25(10). 2245–2253. 199 indexed citations
18.
Odate, Seiichi, Veronica Veschi, Shuang Yan, et al.. (2016). Inhibition of STAT3 with the Generation 2.5 Antisense Oligonucleotide, AZD9150, Decreases Neuroblastoma Tumorigenicity and Increases Chemosensitivity. Clinical Cancer Research. 23(7). 1771–1784. 47 indexed citations
19.
Lam, Norris, et al.. (2016). Identification of CASZ1 NES reveals potential mechanisms for loss of CASZ1 tumor suppressor activity in neuroblastoma. Oncogene. 36(1). 97–109. 19 indexed citations
20.
Tong, Macy, et al.. (2013). Improving Service Provision to Manage Chemotherapy-induced Neutropenic Fever in an Oncology Unit. Hong Kong Journal of Radiology. 16(2). 123–130. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026